Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer-Reference-Cited by-同舟云学术

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

Published:2005-09 Issue:1 Volume:93 Page:67-74
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Ramaswamy Bhuvaneswari,Povoski Steven P,Rhoades Chris,Allen Joan,Hauger Marsha,Young Donn,Burak William,Farrar William,Yee Lisa,Kendra Kari,Somasundaram Sivagurunathan,Orlowski Robert Z,Shapiro Charles L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-005-3784-z.pdf

Reference49 articles.

1. Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer

2. Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

3. Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC) — A Hungarian experience in the BCIRG 001 trial

4. Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy;Revista Latino-Americana de Enfermagem;2014-04

2. Citrus Limonin Lacks the Antichemotherapeutic Effect in Human Models of Breast Cancer;Journal of Nutrigenetics and Nutrigenomics;2012

3. A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer;Community Oncology;2011-05

4. Ocorrência de neutropenia em mulheres com câncer de mama durante tratamento quimioterápico;Acta Paulista de Enfermagem;2011

5. Phase II Trial of Dose Dense Docetaxel Followed by FEC100 as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer;American Journal of Clinical Oncology;2010-12